Blue Streak Science Podcast

Blue Streak Science News Biologists find unexpected role for amyloid-forming protein New duck-billed dinosaur found in Alaska Supermoon! The Associated Press style change gives 'climate skeptics' the boot Perplexing Pluto: New ‘Snakeskin’ Image and More from New Horizons Early Life infections may be a risk factor for Celiac disease in childhood Liquid water on the surface of Mars! Viruses join fight against harmful bacteria Flower declines shrink bee tongues The Jackass of the Week Our Jackass of the Week is Martin Shkreli. Shkreli is a 32 year old hedge fund manager specializing in healthcare companies. Shkreli’s company, Turing Pharmaceuticals bought the rights to the toxoplasmosis drug Daraprim last month, and from his responses to the outrage it seems he is embracing his title as the most hated man, and the Blue Streak Science Jackass of the Week. He’s taken to Twitter and hurled insults, calling people “morons”, criticizing Twitter itself by saying that it “seems to be a great medium for socialist and